weight gain after stopping glp-1 Patients with Higher Initial BMIs and Greater Loss While on GLP-1s Most Likely to Maintain or Continue Weight Loss GLP-1s The Data Are Clear: Patients

Zhang X, Wall M, Sui Z et al (2017) Discovery of orally efficacious tetrahydrobenzimidazoles as TGR5 agonists for type 2 diabetes

Coverage and Cost Check what your insurance covers and whether youd need prior authorization for either medication

The US study analysed 606,434 US veterans with type 2 diabetes, who were monitored for up to three years

Common reported effects include nausea, upset stomach, and digestive discomfort, which often improve as the body adjusts to the medication

Both diabetes and depression are common chronic conditions which reduce a patients functionality, quality of life and life expectancy